Create a narrative

Tempus AI Community

NasdaqGS:TEM Community

1 Narratives written by author
0 Comments on narratives written by author
168 Fair Values set on narratives written by author

AN

AnalystConsensusTarget

AnalystConsensusTarget

Consensus Narrative from 10 Analysts

Expanding Genomic Testing And AI Will Build Lasting Healthcare Value

Key Takeaways Strong growth in testing volumes and biopharma partnerships positions Tempus AI for durable revenue gains, supported by differentiated technology and a growing data advantage. Expanding clinical-genomic offerings and disciplined cost management drive improving profitability, while rising AI adoption and regulatory clarity provide long-term growth opportunities.

US$69.50

FV

15.9% overvalued

29.79%

Revenue growth p.a.

0

0

100

9 days ago